Trio Petroleum Corp. — Form 10-Q Summary
Reporting period: Three and nine months ended July 31, 2023; filed September 11, 2023. The interim financial statements are unaudited. Trio is an exploration-stage oil and gas company focused primarily on the South Salinas Project (SSP) in California and reported no operating revenue.
Key financial metrics
| Metric | Three months ended July 31, 2023 | Nine months ended July 31, 2023 |
|---|---|---|
| Revenue | $0 | $0 |
| Operating expenses | $2.16 million | $3.34 million |
| Net loss | $2.17 million | $5.22 million |
| Basic and diluted loss per share | $0.08 | $0.25 |
| Cash used in operating activities | $2.54 million for the nine-month period | |
| Cash used in investing activities | $1.80 million for the nine-month period | |
| Cash provided by financing activities | $5.78 million for the nine-month period |
At July 31, 2023, cash was $1.51 million, working capital was $0.81 million, total assets were $11.17 million, and total liabilities were $0.87 million. Notes payable were fully repaid or converted by that date; current liabilities were $0.82 million. Oil and gas properties, all classified as unproved and not subject to amortization, were $9.05 million. No margin measure is meaningful given the absence of revenue.
Changes versus comparable periods
- Third-quarter net loss increased from $0.71 million in 2022 to $2.17 million in 2023, principally as operating expenses rose to $2.16 million from $0.22 million. General and administrative expense and stock-based compensation were significant contributors.
- Nine-month net loss increased from $3.09 million to $5.22 million. Operating expenses increased by $2.62 million; other expenses declined overall, partly because prior-year penalty fees were absent, while 2023 included a $1.13 million loss on note conversion.
- Cash increased from $73,648 at October 31, 2022 to $1.51 million at July 31, 2023. Working capital improved from a $4.96 million deficit to $0.81 million, reflecting IPO-related debt conversion and repayments.
- The April 2023 IPO generated $6.0 million gross proceeds and approximately $4.94 million net proceeds. The company also received $1.81 million net from warrant exercises. Common shares outstanding rose from 16.97 million at October 31, 2022 to 29.62 million at July 31, 2023.
Operations, outlook and risks
- Trio reported drilling the HV-1 confirmation well beginning in May 2023. It announced oil and gas shows and stated that swabbing tests had reached rates of up to 125 barrels of oil per day, with associated gas and water, by the end of August. The filing cautions that these preliminary swab results may not be definitive.
- The company planned further testing of the Brown Zone and potentially the Yellow Zone. It expected to drill HV-2 and HV-4 in the latter half of 2023 only if adequate funding was available. These plans are forward-looking, not assurances of production or commercial success.
- Management and the financial statements identify substantial doubt about the company’s ability to continue as a going concern. Trio had an accumulated deficit of $9.13 million, no revenue, and expects to need additional capital; future financing may not be available on acceptable terms or in time. Management said available cash and working capital were expected to cover anticipated needs for the next 12 months, while also stating that additional funding would be needed for planned development and drilling.
- Trio was still evaluating a possible acquisition of Union Ave Field interests, a potential related-party transaction involving Trio LLC, which has ties to company management. A special board committee was evaluating and negotiating terms; no completed acquisition was reported.
- Unusual items included $1.13 million of loss on note conversion, $0.90 million of nine-month stock-based compensation, and a July warrant amendment that reduced the exercise price and increased warrant count to induce exercise. The filing reported no current legal proceedings and no material changes to previously disclosed risk factors.
Important facts for investors to verify
- Whether follow-up HV-1 testing confirms sustained, commercial production, and how the preliminary swab results compare with later test data.
- The status and funding requirements for HV-2 and HV-4, and whether additional capital is secured without material dilution or unfavorable terms.
- The company’s reserve status: the filing states there were no proved reserves attributable to the approximately 9,300-acre SSP, while its discussion of planned zone testing refers to reserves in a reserve report. Clarify the scope and status of those statements.
- Whether any Union Ave Field transaction proceeds, including its related-party terms, valuation, and required approvals.
- Potential dilution from outstanding warrants, equity awards, and future financing; the filing reported 1,459,878 warrants outstanding at July 31, 2023.